Background Pharmacies sometimes restrict access to buprenorphine-naloxone
(buprenorphine) for individuals with opioid use disorder. The objective of this study was to …

Medications for opioid use disorder (MOUD), such as methadone and buprenorphine, are
effective strategies for treatment of opioid use disorder (OUD) and reducing overdose risk …

Abstrak− Website adalah layanan komputer yang terkoneksi dengan fasilitas hypertext. User
Interface (UI) yang buruk akan berpengaruh terhadap User Experience (UX), sehingga …

ABSTRACT Background and Aims Physician and pharmacist collaboration may help
address the shortage of buprenorphine‐waivered physicians and improve care for patients …

The opioid crisis represents one of the largest failures of our current health care system as it
continues to claim lives at an unprecedented rate and has caused a devastating range of …

Purpose Strategies for deploying clinical pharmacists to increase access to buprenorphine
in inpatient, outpatient and transitional care, and community practice settings are described …

In the last decade, the US opioid overdose crisis has magnified, particularly since the
introduction of synthetic opioids, including fentanyl. Despite the benefits of medications for …

EXECUTIVE SUMMARY The 2020 Special Committee on Substance Use and Pharmacy
Education was charged to update the work of the 2010 Special Committee on Substance …

Objectives To characterize the instructional settings, delivery methods, and assessment
methods of opioid use disorder (OUD) content in Doctor of Pharmacy (PharmD) programs; …

Background: Continuing education (CE) provides educational opportunities for health
professionals to adequately respond to issues in practice but infrequently evaluate …